ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
88,200
-800 (-0.90%)
At close: Apr 27, 2026
Market Cap 1.29T
Revenue (ttm) 26.25B
Net Income (ttm) -2.85B
Shares Out 15.74M
EPS (ttm) -222.00
PE Ratio n/a
Forward PE 150.55
Dividend n/a
Ex-Dividend Date n/a
Volume 130,637
Average Volume 436,286
Open 88,400
Previous Close 89,000
Day's Range 87,100 - 89,000
52-Week Range 13,740 - 153,800
Beta n/a
RSI 37.29
Earnings Date Apr 10, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

In 2025, ROKIT Healthcare's revenue was 26.25 billion, an increase of 100.19% compared to the previous year's 13.11 billion. Losses were -2.85 billion, -62.79% less than in 2024.

Financial Statements

News

There is no news available yet.